
|Videos|September 3, 2021
Dr. Allaway discusses potential barriers in implementing transperineal biopsy on a larger scale
Author(s)Urology Times staff
“The 3 major barriers we face [are] training, equipment, and reimbursement,” says Matthew A. Allaway, MD.
Advertisement
In this video, Matthew A. Allaway, MD, discusses the obstacles that practitioners may face when implementing The PrecisionPoint Transperineal Access System into their practices. Allaway is the founder and president of Perineologic, urologist and managing partner at Urology Associates, Cumberland, Maryland.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
4
Sarah Azari, MD, on early sexual health education for women with bladder cancer
5






